Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Selected Publications (2012-2017)

  1. Geletneky, K., Huesing, J., Rommelaere, J., Schlehofer, J.R., Dahm, M., Krebs, O., von Knebel     Doeberitz, M., Huber, B. and Hajda, J. (2012). Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol. BMC Cancer, 12:99.
  2. Grekova, S.P., Raykov, Z., Zawatzky, R., Rommelaere, J. and Koch, U. (2012). Activation of a glioma-specific immune response by oncolytic minute virus of mice infection. Cancer Gene Ther, 19:468-475.
  3. Raykov, Z., Grekova, S., Hörlein, R., Leuchs, B., Giese, T., Giese, N.A., Rommelaere, J., Zawatzky, R., Daeffler, L. (2013). TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells. PLOS ONE, 8:e55086.
  4. Bhat, R. and Rommelaere, J. (2013). NK cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by an oncolytic virus. BMC Cancer, 13:367.
  5. Angelova, A., Grekova, S., Heller, A., Kuhlmann, O., Soyka, E., Giese, T., Aprahamian, M., Bour, G., Rüffer, S., Cziepluch, C., Daeffler, L., Rommelaere, J., Werner, J., Raykov, Z. and Giese, N. (2014). Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. J Virol, 88:5263-5276.
  6. Grekova, S.P., Aprahamian, M., Giese, N.A., Bour, G., Giese, T., Grewenig, A., Leuchs, B., Hörlein, R., Heller, A., Angelova, A.L., Rommelaere, J., Raykov, Z. (2014). Genomic CpG enrichment of oncolytic parvoviruses as a potent anticancer vaccination strategy for the treatment of pancreatic adenocarcinoma. Journal of Vaccines and Vaccination, 5:227.
  7. Geletneky, K., Nüesch, J.P., Angelova, A., Kiprianova, I. and Rommelaere, J. (2015). Double-faceted mechanism of parvoviral oncosuppression. Curr Opin Virol, 13:17.
  8. Geletneky, K., Leoni, A.L., Pohlmeyer-Esch, G., Loebhard, S., Leuchs, B., Hoefer, C., Johims, K., Dahm, M., Huber, B., Rommelaere, J., Krebs, O. and Hajda, J. (2015). Bioavailability, biodistribution, and CNS toxicity of clinical grade parvovirus H1 after intravenous and intracerebral injection in rats. Comparative Medicine, 65:36-45.
  9. Geletneky, K., Leoni, A.L., Pohlmeyer-Esch, G., Loebhard, S., Baetz, A., Leuchs, B., Roscher, M., Hoefer, C., Johims, K., Dahm, M., Huber, B., Rommelaere, J., Krebs, O. and Hajda, J. (2015). Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical grade parvovirus H1. Comparative Medicine, 65:23-35.
  10. Vassaux, G., Angelova, A., Baril, P., Midoux, P., Rommelaere, J. and Cordelier, P. (2016). The promise of gene therapy for pancreatic cancer. Hum Gene Ther, 27:127-133.
  11. Heller, A., Angelova, A.L., Bauer, S., Grekova, S.P., Aprahamian, M., Rommelaere, J., Volkmar, M., Janssen, J.W., Bauer, N., Herr, I., Giese, T., Gaida, M.M., Bergmann, F., Hackert, T., Fritz, S. and Giese, N.A. (2016). Establishment and characterization of a novel cell line, ASAN-PaCa, derived from human adenocarcinoma arising in intraductal papillary mucinous neoplasm of the pancreas. Pancreas, 45:1452-1460.
  12. Nettelbeck, D., Ungerechts, G., Bussow, S., Leuchs, B., Holm, P.S., Rommelaere, J., Coffey, M., Coffin, R., Bell, J. (2016). Moving oncolytic viruses into the clinic – clinical grade production, purification and characterization of diverse oncolytic viruses. Mol Ther-Methods&Clinical Development, 3:16018.
  13. Geletneky, K., Hajda, J., Angelova, A.L., Leuchs, B., Capper, D., Bartsch, A.J., Neumann, J.O., Schöning, T., Hüsing, J., Beelte, B., Kiprianova, I., Roscher, M., Bhat, R., von Deimling, A., Brück, W., Just, A., Frehtman, V., Löbhard, S., terletskaia-Ladwig, E., Fry, J., Jochims, K., Daniel, V., Krebs, O., Dahm, M., Huber, B., Unterberg, A., Rommelaere, J. (2017). Oncolytic H-1 parvovirus shows safety and signs of immunogenic activity in a first phase I/IIa glioblastoma trial. Mol Ther, 25, in press.
  14. Hajda, J., Lehmann, M.; Krebs, O., Kieser, M., Geletneky, K., Jäger, D., Dahm, M., Huber, B., Schöning, T., Sedlaczek, O., Stenzinger, A., Halama, N., Volker, D., Leuchs, B., Angelova, A., Rommelaere, J., Engeland, C.E., Springfeld, C., Ungerechts, G. (2017). A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol. BMC Cancer, 17:576.
  15. Angelova, A.L., Witzens-Harig, M., Galabov, A.S., Rommelaere, J. (2017). The oncolytic virotherapy era in cancer management: prospects of applying H-1 parvovirus to treat blood and solid cancers. Front Oncol, 7:93.
  16. Ungerechts, G., Engeland, C., Buchholz, C., Eberle, J., Fechner, H., Geletneky, K., Holm, P., Kreppel, F., Kühnel, F., Lang, K., Leber, M., Marchini, A., Moehler, M., Mühlenbach, M., Rommelaere, J., Springfeld, C., Lauer, U., Nettelbeck, D. (2017). Virotherapy research in Germany – from engineering to translation. Hum Gene Ther, 28:800-819.

            … and 8 granted patents

to top
powered by webEdition CMS